Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2.

Sueta D, Yamashita Y, Morimoto T, Chatani R, Nishimoto Y, Kaneda K, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Shioyama W, Dohke T, Nishikawa R, Kimura T, Tsujita K, COMMAND VTE Registry-2 Investigators

Open source

DOI: 10.1055/a-2316-5269
Published: 2024 Nov
Container: Thrombosis and haemostasis
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1055/a-2316-5269,
  title = {Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2.},
  author = {Sueta D and Yamashita Y and Morimoto T and Chatani R and Nishimoto Y and Kaneda K and Ikeda N and Kobayashi Y and Ikeda S and Kim K and Inoko M and Takase T and Tsuji S and Oi M and Takada T and Otsui K and Sakamoto J and Ogihara Y and Inoue T and Usami S and Chen PM and Togi K and Koitabashi N and Hiramori S and Doi K and Mabuchi H and Tsuyuki Y and Murata K and Takabayashi K and Nakai H and Shioyama W and Dohke T and Nishikawa R and Kimura T and Tsujita K and COMMAND VTE Registry-2 Investigators},
  year = {2024},
  journal = {Thrombosis and haemostasis},
  doi = {10.1055/a-2316-5269},
  url = {https://doi.org/10.1055/a-2316-5269}
}

RIS

TY  - JOUR
TI  - Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2.
AU  - Sueta D
AU  - Yamashita Y
AU  - Morimoto T
AU  - Chatani R
AU  - Nishimoto Y
AU  - Kaneda K
AU  - Ikeda N
AU  - Kobayashi Y
AU  - Ikeda S
AU  - Kim K
AU  - Inoko M
AU  - Takase T
AU  - Tsuji S
AU  - Oi M
AU  - Takada T
AU  - Otsui K
AU  - Sakamoto J
AU  - Ogihara Y
AU  - Inoue T
AU  - Usami S
AU  - Chen PM
AU  - Togi K
AU  - Koitabashi N
AU  - Hiramori S
AU  - Doi K
AU  - Mabuchi H
AU  - Tsuyuki Y
AU  - Murata K
AU  - Takabayashi K
AU  - Nakai H
AU  - Shioyama W
AU  - Dohke T
AU  - Nishikawa R
AU  - Kimura T
AU  - Tsujita K
AU  - COMMAND VTE Registry-2 Investigators
PY  - 2024
JO  - Thrombosis and haemostasis
DO  - 10.1055/a-2316-5269
UR  - https://doi.org/10.1055/a-2316-5269
ER  -

APA

D, S., Y, Y., T, M., R, C., Y, N., K, K., N, I., Y, K., S, I., K, K., M, I., T, T., S, T., M, O., T, T., K, O., J, S., Y, O., T, I., S, U., PM, C., K, T., N, K., S, H., K, D., H, M., Y, T., K, M., K, T., H, N., W, S., T, D., R, N., T, K., K, T., & Investigators, C. V. R. (2024). Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2.. Thrombosis and haemostasis. https://doi.org/10.1055/a-2316-5269

Source records

pubmed · retrieved 2026-09-25T05:58:42.467Z